Advances of PD-1/PD-L1 Signaling Pathway in Immune Escape and Treatment for 
Non-small Cell Lung Cancer

Advances of PD-1/PD-L1 Signaling Pathway in Immune Escape and Treatment for 
Non-small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related mortality worldwide. Despiting the great progress on target agents, majority of people who do not harbor a mutation could not get benefit from them. Immunotherapy, through stimulating the body's immune system to improve the antitumor immunity e...

Full description

Bibliographic Details
Main Authors: Cheng LIN, Xiong CHEN, Jingnan LIU, Yufang HUANG, Xuenong OU-YANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Programmed death 1
Programmed death 1 ligand
Immuno-therapy
Checkpoint inhibitors
Immune escape
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.05

Similar Items